CHICAGO (April 11, 2024) — Cars.com Inc. (NYSE: CARS) (d/b/a “Cars Commerce Inc.”), an audience-driven technology company empowering the automotive industry, today launched its March Industry Insights ...
A pioneering Phase I CAR T cell therapy trial for the treatment of glioblastoma at City of Hope demonstrates promising clinical activity against incurable brain tumors, according to research published ...
A naturally occurring byproduct of liver metabolism–the ketone body, β-hydroxybutyrate (BHB)–can strengthen the fitness and antitumor activity of CAR T cells. The findings, reported on March 6, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results